OnKure Therapeutics Q2 EPS $0.31 Beats $(0.54) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.54) by 158.49 percent. This is a 127.19 percent increase over losses of $(1.14) per share
OnKure made money this quarter instead of losing it, which is much better than what experts thought would happen. When a company surprises people by doing way better than expected, it can mean the business is getting stronger.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.